Your browser doesn't support javascript.
loading
Insulin doses requirements in patients with type 1 diabetes using glargine U300 or degludec in routine clinical practice.
Carral San Laureano, Florentino; Tomé Fernández-Ladreda, Mariana; Jiménez Millán, Ana Isabel; García Calzado, Concepción; Ayala Ortega, María Del Carmen.
  • Carral San Laureano F; Endocrinology and Nutrition, University Hospital of Puerto Real, Puerto Real, Andalucía, Spain florencarral@hotmail.com.
  • Tomé Fernández-Ladreda M; Endocrinology and Nutrition, University Hospital of Puerto Real, Puerto Real, Andalucía, Spain.
  • Jiménez Millán AI; Endocrinology and Nutrition, University Hospital of Puerto Real, Puerto Real, Andalucía, Spain.
  • García Calzado C; Endocrinology and Nutrition, University Hospital of Puerto Real, Puerto Real, Andalucía, Spain.
  • Ayala Ortega MDC; Endocrinology and Nutrition, University Hospital of Puerto Real, Puerto Real, Andalucía, Spain.
J Investig Med ; 69(5): 983-988, 2021 06.
Article en En | MEDLINE | ID: mdl-33771843
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Insulina de Acción Prolongada / Diabetes Mellitus Tipo 1 / Insulina Glargina / Hipoglucemiantes Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Insulina de Acción Prolongada / Diabetes Mellitus Tipo 1 / Insulina Glargina / Hipoglucemiantes Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article